Abstract:Human kallikrein-related peptidases (KLKs) are a group of 15 secreted serine proteases encoded by the largest contiguous cluster of protease genes in the human genome. KLKs are involved in coordination of numerous physiological functions including regulation of blood pressure, neuronal plasticity, skin desquamation, and semen liquefaction, and thus represent promising diagnostic and therapeutic targets. Until now, quantification of KLKs in biological and clinical samples was accomplished by enzyme-linked immunosorbent assays (ELISA). Here, we developed multiplex targeted mass spectrometry assays for the simultaneous quantification of all 15 KLKs. Proteotypic peptides for each KLK were carefully selected based on experimental data and multiplexed in single assays. Performance of assays was evaluated using three different mass spectrometry platforms including triple quadrupole, quadrupole-ion trap, and quadrupole-orbitrap instruments. Heavy isotope-labeled synthetic peptides with a quantifying tag were used for absolute quantification of KLKs in sweat, cervico-vaginal fluid, seminal plasma, and blood serum, with limits of detection ranging from 5 to 500 ng/ml. Analytical performance of assays was evaluated by measuring endogenous KLKs in relevant biological fluids, and results were compared with selected ELISAs. The multiplex targeted proteomic assays were demonstrated to be accurate, reproducible, sensitive, and specific alternatives to antibody-based assays. Finally, KLK4, a highly prostate-specific protein and a speculated biomarker of prostate cancer, was unambiguously detected and quantified by immunoenrichment-SRM assay in seminal plasma and blood serum samples from individuals with confirmed prostate cancer and negative biopsy. Mass spectrometry revealed exclusively the presence of a secreted isoform and thus unequivocally resolved earlier disputes about KLK4 identity in seminal plasma. Measurements of KLK4 in either 41 seminal plasma or 58 blood serum samples revealed no statistically significant differences between patients with confirmed prostate cancer and negative biopsy. The presented multiplex targeted proteomic assays are an alternative analytical tool to study the biological and pathological roles of human KLKs.

Identification of the related proteins of tissue kallikrein in brain using mass spectrometry

Proteomics Identification of Proteins in Human Cortex Using Multidimensional Separations and MALDI Tandem Mass Spectrometer

Identification of a new tissue-kallikrein-binding protein

Optimization of the Isolation and Enrichment of S-Nitrosylated Proteins from Brain Tissues of Rodents and Humans with Various Prion Diseases for Itraq-Based Proteomics

Tissue-Specific Expression And Promoter Analyses Of The Human Tissue Kallikrein Gene In Transgenic Mice

Tissue Kallikrein Protects Neurons from Hypoxia/reoxygenation-Induced Cell Injury Through Homer1b/c.

Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays

Identification of a key protein associated with cerebral ischemia.

Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase.

Rat Brain Capillary Thrombomodulin

Interaction between Acid-Sensing Ion Channels and Tissue Kallikrein

Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry

Different Expression Patterns of Ck2 Subunits in the Brains of Experimental Animals and Patients with Transmissible Spongiform Encephalopathies

Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies

Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1.

[Preparation, Identification, and Analysis on Tissue Chips of Polyclonal Anti-Peptide Antibody to Chemokine-Like Factor 1].

Identification of Site-Specific Stroke Biomarker Candidates by Laser Capture Microdissection and Labeled Reference Peptide

The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury.

EXTRACTION AND IDENTIFICATION OF THE PROTIEN BAND OF 220 000 IN NERVE REGENERATION CONDITIONED FLUID

[A Preliminary Proteomic Analysis of Tauopathies].

Expression and cellular localization of the kallikrein-kinin system in human ocular tissues